核酸口服液的药理研究  

Pharmacological Studies of Nucleic Acid Oral Solution

作　　者：张岫美[1] 魏欣冰[1] 盛少虎[1] 贾伟 侯宗良 李建淮 

机构地区：[1]山东医科大学基础医学院药理学教研室,250012 [2]济南市食品科学研究所

出　　处：《中国生化药物杂志》1998年第3期121-123,共3页Chinese Journal of Biochemical Pharmaceutics

基　　金：国内贸易部资助

摘　　要：核糖核酸制剂核酸口服液能提高正常及免疫功能低下动物的非特异性免疫功能，促进正常小鼠的血清溶血素生成，增强体液免疫功能。对正常小鼠的血糖水平及中枢神经系统功能无明显影响。The pharmacological studies of nucleic acid oral solution (NAOS) were investigated. The results show that NAOS was able to enhance the phagocytic activity of Peritoneal macrophage and the production of serum hemolysin in normal and in immunodepressive mice caused by dexamethasone remarkably. No significant effects on the normal serum glucose level and hypnotization induced by pentobarbital in mice.

关 键 词：核酸口服液 核糖核酸 吞噬功能 溶血素 药理 

分 类 号：R977[医药卫生—药品]